| Literature DB >> 21134349 |
Andreas Weiss1, Stephan Grueninger, Dorothée Abramowski, Francesco Paolo Di Giorgio, Miriam Moscovitch Lopatin, H Diana Rosas, Steven Hersch, Paolo Paganetti.
Abstract
Huntington's disease is caused by a gain-of-function neurotoxic mutation in normally neuroprotective huntingtin. Sensitive assays are required to discriminate mutant huntingtin from wild-type huntingtin. We have developed a normalized 384-plate assay for determination of mutant and wild-type huntingtin. Based on a single pipetting step, the sensitive assay uses two antibody pairs for simultaneous mutant and wild-type huntingtin time-resolved fluorescence resonance energy transfer detection combined with PicoGreen quantification of double-stranded DNA. The assay can be used for discovery of drugs reducing mutant huntingtin over wild-type huntingtin and for assessing the value of huntingtin as a disease progression marker, and it is adaptable to other proteins of interest.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21134349 DOI: 10.1016/j.ab.2010.11.044
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365